Improving PrEP adherence for young gay and bisexual men
RP3 PrEP Choice
['FUNDING_OTHER'] · FLORIDA STATE UNIVERSITY · NIH-10993605
This study is all about helping young gay and bisexual men, ages 13-24, start and stick with taking PrEP to prevent HIV, using friendly mobile tools like a helpful website, text reminders, and an app, all designed to fit their needs and language.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FLORIDA STATE UNIVERSITY (nih funded) |
| Locations | 1 site (TALLAHASSEE, UNITED STATES) |
| Trial ID | NIH-10993605 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the uptake and adherence to pre-exposure prophylaxis (PrEP) among young gay, bisexual, and other men who have sex with men (YGBMSM) aged 13-24 years. It utilizes a combination of mobile health tools, including a website to help users choose the best PrEP regimen, a two-way SMS texting service for weekly check-ins, and an app that reminds users to take their medication. The study aims to assess the effectiveness of these tools in increasing the number of young individuals who start and consistently use PrEP to prevent HIV infection. The research will also ensure that the tools are culturally relevant for both English and Spanish speakers through focus groups.
Who could benefit from this research
Good fit: Ideal candidates for participation are young gay, bisexual, and other men who have sex with men aged 13-24 years who are at risk for HIV.
Not a fit: Patients who are not at risk for HIV or who are outside the age range of 13-24 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of young individuals effectively using PrEP, thereby reducing new HIV infections in this high-risk population.
How similar studies have performed: Previous research has shown success with mobile health interventions for improving medication adherence, making this approach promising yet innovative in the context of PrEP.
Where this research is happening
TALLAHASSEE, UNITED STATES
- FLORIDA STATE UNIVERSITY — TALLAHASSEE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HIGHTOW-WEIDMAN, LISA B — FLORIDA STATE UNIVERSITY
- Study coordinator: HIGHTOW-WEIDMAN, LISA B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus